HOME
ABOUT
RESEARCH
PRODUCTS
INVESTORS
- ASX ANNOUNCEMENTS
  - 2021
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
- PRESENTATIONS & VIDEOS
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
  - 2015
- REPORTS
- STOCK INFORMATION
- CORPORATE GOVERNANCE
MEDIA
CONTACT

HOME
ABOUT
RESEARCH
PRODUCTS
INVESTORS
- - ASX ANNOUNCEMENTS
  - - 2021
  - - 2020
  - - 2019
  - - 2018
  - - 2017
  - - 2016
- - PRESENTATIONS & VIDEOS
  - - 2020
  - - 2019
  - - 2018
  - - 2017
  - - 2016
  - - 2015
- - REPORTS
- - STOCK INFORMATION
- - CORPORATE GOVERNANCE
MEDIA
CONTACT

REPORTS

REPORTS

Date	Title
19/08/2020	Sequoia Initiation Research Report, 19 August 2020
24/01/2019	Viriathus Research Report, 13 September 2018

SUBSCRIBE

Leave this field empty if you're human:

Zelira TherapeuticsFollow

This year Zelira achieved a number of key commercial and clinical milestones that marked its successful transition to the ‘Launch, Learn and Develop’ model for rapid commercialisation.
#ZLD #ZLDAF #autism #insomnia #clinicaltrials
https://t.co/B8RNItl4mS

CONTACT US

Copyright © Zelira Therapeutics. All rights reserved. | Disclaimer.